In-silico profiling of deleterious non-synonymous single nucleotide polymorphisms of ARSA (arylsulphatase A) for enhanced diagnosis of metachromatic leukodystrophy

[1]  D. Singh,et al.  Simulation studies, 3D QSAR and molecular docking on a point mutation of protein kinase B with flavonoids targeting ovarian Cancer , 2021, BMC pharmacology & toxicology.

[2]  M. Hossain,et al.  In silico analysis predicting effects of deleterious SNPs of human RASSF5 gene on its structure and functions , 2020, Scientific Reports.

[3]  Changhe Shi,et al.  ARSA gene variants and Parkinson's disease. , 2020, Brain : a journal of neurology.

[4]  M. Daly,et al.  MISCAST: MIssense variant to protein StruCture Analysis web SuiTe , 2020, Nucleic Acids Res..

[5]  Suhail A. Islam,et al.  Can Predicted Protein 3D Structures Provide Reliable Insights into whether Missense Variants Are Disease Associated? , 2019, Journal of molecular biology.

[6]  Daniel W. A. Buchan,et al.  The PSIPRED Protein Analysis Workbench: 20 years on , 2019, Nucleic Acids Res..

[7]  F. Romer,et al.  In Silico Analysis of the Novel Variant Q375R in the Phenylalanine Hydroxylase Gene , 2019, Gene, Cell and Tissue.

[8]  C. Whitley,et al.  Phenotype prediction for mucopolysaccharidosis type I by in silico analysis , 2017, Orphanet Journal of Rare Diseases.

[9]  F. Eichler,et al.  Metachromatic Leukodystrophy , 2016, Journal of child neurology.

[10]  Itay Mayrose,et al.  ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules , 2016, Nucleic Acids Res..

[11]  N. Wolf,et al.  Metachromatic leukodystrophy: Disease spectrum and approaches for treatment. , 2015, Best practice & research. Clinical endocrinology & metabolism.

[12]  S. Groeschel,et al.  Language and cognition in children with metachromatic leukodystrophy: onset and natural course in a nationwide cohort , 2014, Orphanet Journal of Rare Diseases.

[13]  Daniel W. A. Buchan,et al.  Scalable web services for the PSIPRED Protein Analysis Workbench , 2013, Nucleic Acids Res..

[14]  C. Doss,et al.  Screening of mutations affecting protein stability and dynamics of FGFR1—A simulation analysis , 2012, Applied & translational genomics.

[15]  I. Krägeloh-Mann,et al.  The natural course of gross motor deterioration in metachromatic leukodystrophy , 2011, Developmental medicine and child neurology.

[16]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[17]  I. Krägeloh-Mann,et al.  Metachromatic Leukodystrophy – An Update , 2010, Neuropediatrics.

[18]  Michael McDuffie,et al.  FlexPred: a web-server for predicting residue positions involved in conformational switches in proteins , 2008, Bioinformation.

[19]  V. Gieselmann.  Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options , 2008, Acta paediatrica.

[20]  H. Moser,et al.  Late-onset metachromatic leukodystrophy , 2006, Neurology.

[21]  Arlo Z. Randall,et al.  Prediction of protein stability changes for single‐site mutations using support vector machines , 2005, Proteins.

[22]  O. Amaral,et al.  Prevalence of lysosomal storage diseases in Portugal , 2004, European Journal of Human Genetics.

[23]  R. A. Wevers,et al.  The frequency of lysosomal storage diseases in The Netherlands , 1999, Human Genetics.

[24]  V. Gieselmann,et al.  Occurrence, distribution, and phenotype of arylsulfatase A mutations in patients with metachromatic leukodystrophy. , 1997, American journal of medical genetics.

[25]  S. Regis,et al.  Molecular analysis of the arylsulphatase A gene in late infantile metachromatic leucodystrophy patients and healthy subjects from Italy. , 1996, Journal of medical genetics.

[26]  T M Hyde,et al.  Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis. , 1992, Archives of neurology.

[27]  K. Figura,et al.  Molecular genetics of metachromatic leukodystrophy , 1991, Human mutation.

[28]  K. Sandhoff,et al.  Sulfatide activator protein. Alternative splicing that generates three mRNAs and a newly found mutation responsible for a clinical disease. , 1991, The Journal of biological chemistry.

[29]  K. von Figura,et al.  Molecular basis of different forms of metachromatic leukodystrophy. , 1991, The New England journal of medicine.

[30]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[31]  Y. Eto,et al.  [Metachromatic leukodystrophy]. , 1998, Ryoikibetsu shokogun shirizu.